Unicentric Castleman Disease Relapsed After Rituximab-CHOP Chemotherapy or Radiation Therapy in an Adolescent
Journal of Pediatric Hematology/Oncology, 06/29/2012
Baek HJ et al. – The authors report the case with relapsed unicentric–plasma cell variant CD who was eventually treated with complete surgical resection. This patient had no response to combination chemotherapy with rituximab after incomplete resection and no response to radiation after relapse.